Juárez-Mercado, K.E.; Gómez-Hernández, M.A.; Salinas-Trujano, J.; Córdova-Bahena, L.; Espitia, C.; Pérez-Tapia, S.M.; Medina-Franco, J.L.; Velasco-Velázquez, M.A.
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning. Pharmaceuticals 2024, 17, 240.
https://doi.org/10.3390/ph17020240
AMA Style
Juárez-Mercado KE, Gómez-Hernández MA, Salinas-Trujano J, Córdova-Bahena L, Espitia C, Pérez-Tapia SM, Medina-Franco JL, Velasco-Velázquez MA.
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning. Pharmaceuticals. 2024; 17(2):240.
https://doi.org/10.3390/ph17020240
Chicago/Turabian Style
Juárez-Mercado, Karina EurÃdice, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, Luis Córdova-Bahena, Clara Espitia, Sonia Mayra Pérez-Tapia, José L. Medina-Franco, and Marco A. Velasco-Velázquez.
2024. "Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning" Pharmaceuticals 17, no. 2: 240.
https://doi.org/10.3390/ph17020240
APA Style
Juárez-Mercado, K. E., Gómez-Hernández, M. A., Salinas-Trujano, J., Córdova-Bahena, L., Espitia, C., Pérez-Tapia, S. M., Medina-Franco, J. L., & Velasco-Velázquez, M. A.
(2024). Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning. Pharmaceuticals, 17(2), 240.
https://doi.org/10.3390/ph17020240
